Comparison of open and endovascular repair of complex abdominal aortic aneurysms

Sai Divya Yadavalli1, Vinamr Rastogi2, Ambar Mehta3

  • 1Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

PubMed

Insights

Endovascular repair (FEVAR) offers lower perioperative mortality for complex abdominal aortic aneurysms (cAAA) in males but shows similar short-term outcomes in females. Long-term, FEVAR in females leads to higher reintervention and mortality rates compared to open repair (OAR).

Area of Science:

  • Vascular Surgery
  • Endovascular Interventions
  • Aortic Aneurysm Repair

Background:

  • Complex abdominal aortic aneurysms (cAAAs) require careful consideration of repair strategies.
  • Sex-based differences in outcomes after aortic aneurysm repair are increasingly recognized.
  • Endovascular aneurysm repair (EVAR) and open surgical repair (OSR) are primary treatment options.

Purpose of the Study:

  • To compare perioperative and 5-year outcomes of fenestrated endovascular aortic repair (FEVAR) versus open repair (OAR) for cAAAs.
  • To analyze outcomes separately in males and females to identify sex-specific differences.
  • To inform clinical decision-making and future research directions for cAAA treatment.

Main Methods:

  • Analysis of elective cAAA repairs from the VISION registry (2014-2019).
  • Stratification of patients by sex and propensity score matching for OAR versus FEVAR.
  • Evaluation of perioperative and 5-year outcomes (mortality, reintervention, rupture) using regression models.

Main Results:

  • FEVAR demonstrated lower perioperative mortality in males, but 5-year outcomes were comparable with OAR, with higher reintervention rates.
  • In females, FEVAR and OAR showed similar perioperative mortality.
  • At 5 years, FEVAR in females was associated with higher mortality and reintervention rates compared to OAR.

Conclusions:

  • FEVAR offers short-term benefits for male cAAA repair, but long-term advantages diminish.
  • FEVAR in females shows no perioperative advantage and is linked to worse long-term outcomes (higher mortality and reintervention).
  • Further research is needed to understand and address sex disparities in FEVAR outcomes, with cautious patient selection advised for females.
Abstract